Skip to main content
See every side of every news story
Published loading...Updated

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

The deal cuts monthly costs of GLP-1 obesity drugs to as low as $149 and expands Medicare and Medicaid coverage to about 10% of Medicare enrollees, officials said.

  • President Trump announced deals with Eli Lilly and Novo Nordisk to cut prices of obesity drugs for Medicare and Medicaid beneficiaries in 2026.
  • The deals will offer obesity treatments directly to consumers at discounted prices on a website called TrumpRx.gov starting in January.
  • Certain Medicare patients will pay $50 per month for approved GLP-1 drugs, and upcoming obesity pills from Lilly and Novo Nordisk will cost $145 per month initially.
Insights by Ground AI
Podcasts & Opinions

284 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 58% of the sources are Center
58% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WSB Radio broke the news in Atlanta, United States on Wednesday, November 5, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal